PG
NXTM

Pendal Group’s NxStage Medical Inc. NXTM Stock Holding History

Pendal Group’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-31,470
Closed -$901K – 471
2018
Q4 		$901K Buy
+31,470
New +$894K 0.01% 280

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Pendal Group's NXTM Position: Q1 2019 in Review

Pendal Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 31,470 shares — an estimated $901K sold.

Pendal Group first reported a position in NXTM in Q4 2018 and held it in 1 quarter. The position peaked at $901K in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Pendal Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Pendal Group sold 31,470 NxStage Medical Inc. shares in Q1 2019, an estimated $901K.
  • Pendal Group first reported a position in NxStage Medical Inc. in Q4 2018 and held it in 1 quarter.
  • Pendal Group's NxStage Medical Inc. position peaked at $901K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Pendal Group's 13F filing for Q1 2019, filed 1 May 2019.